Literature DB >> 2950902

Near-total loss of 'learning' and 'memory' as a result of combined cholinergic and serotonergic blockade in the rat.

C H Vanderwolf.   

Abstract

Previous work has indicated that activation of the cerebral cortex (i.e. elicitation of low-voltage fast activity in the neocortex and rhythmical slow activity in the hippocampus) is dependent on corticipetal cholinergic and serotonergic projections. Treatment with a combination of p-chlorophenylalanine (an inhibitor of the synthesis of serotonin) plus atropine or scopolamine (muscarinic cholinergic antagonists) can suppress all cerebral activation. In this paper, the behavioral effects of single or combined blockade of cholinergic and serotonergic neurotransmission were studied using a shock avoidance test, an open field test, a swim-to-platform test, a hypothalamic self-stimulation test and a test of grooming behavior. The results show that blockade of cerebral activation produces a condition analogous to global dementia but does not produce sleep or coma. The hypothesis that cholinergic and serotonergic neurotransmission provides a basis for learning and memory is discussed critically.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2950902     DOI: 10.1016/0166-4328(87)90241-5

Source DB:  PubMed          Journal:  Behav Brain Res        ISSN: 0166-4328            Impact factor:   3.332


  18 in total

1.  Effects of localized histamine microinjections into the hippocampal formation on the retrieval of a one-way active avoidance response in rats.

Authors:  E O Alvarez; A M Banzan
Journal:  J Neural Transm Gen Sect       Date:  1995

Review 2.  Serotonergic modulation of hippocampal theta activity in relation to hippocampal information processing.

Authors:  María Esther Olvera-Cortés; Blanca Erika Gutiérrez-Guzmán; Elisa López-Loeza; J Jesús Hernández-Pérez; Miguel Angel López-Vázquez
Journal:  Exp Brain Res       Date:  2013-08-30       Impact factor: 1.972

3.  Hyperactivity and intact hippocampus-dependent learning in mice lacking the M1 muscarinic acetylcholine receptor.

Authors:  T Miyakawa; M Yamada; A Duttaroy; J Wess
Journal:  J Neurosci       Date:  2001-07-15       Impact factor: 6.167

4.  Structures mediating cholinergic reticular facilitation of cortical responses in the cat: effects of lesions in immunocytochemically characterized projections.

Authors:  C M Müller; M H Lewandowski; W Singer
Journal:  Exp Brain Res       Date:  1993       Impact factor: 1.972

5.  Memory disorders associated with consumption of drugs: updating through a case/noncase study in the French PharmacoVigilance Database.

Authors:  Francois Chavant; Sylvie Favrelière; Claire Lafay-Chebassier; Caroline Plazanet; Marie-Christine Pérault-Pochat
Journal:  Br J Clin Pharmacol       Date:  2011-12       Impact factor: 4.335

6.  Effects of oxotremorine on inhibitory avoidance behaviour in two inbred strains of mice: interaction with 5-methoxy-NN-dimethyltriptamine.

Authors:  F Pavone; S Fagioli; C Castellano
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

7.  Independent effects of cholinergic and serotonergic lesions on acetylcholine and serotonin release in the neocortex of the rat.

Authors:  A J Dekker; L J Thal
Journal:  Neurochem Res       Date:  1993-03       Impact factor: 3.996

8.  Antidepressants are a rational complementary therapy for the treatment of Alzheimer's disease.

Authors:  Marwa Aboukhatwa; Laura Dosanjh; Yuan Luo
Journal:  Mol Neurodegener       Date:  2010-03-12       Impact factor: 14.195

9.  Combined treatment with a 5HT1A receptor agonist and a muscarinic acetylcholine receptor antagonist disrupts water maze navigation behavior.

Authors:  M Riekkinen; J Sirviö; T Toivanen; P Riekkinen
Journal:  Psychopharmacology (Berl)       Date:  1995-11       Impact factor: 4.530

10.  Metrifonate effects on acetylcholine and biogenic amines in rat cortex.

Authors:  F Mori; G Cuadra; E Giacobini
Journal:  Neurochem Res       Date:  1995-09       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.